| http://www.w3.org/ns/prov#value | - hed new drugs that stand to change the way conditions such as hepatitis C, stroke and skin cancer are addressed.All told, the industry launched 34 new drugs last year, the most in more than a decade, according to IMS.The new products include hepatitis C drugs Incivek from Vertex Pharmaceuticals and Victrelis from Merck & Co; Bristol-Myers Squibb's Yervoy and Roche Holding AG's and Zelboraf for mel
|
